The Oral Insulin Sensitizer, Thiazolidinedione, Increases Plasma Vascular Endothelial Growth Factor in Type 2 Diabetic Patients

Diabetes Care - United States
doi 10.2337/diacare.24.5.953
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Vascular Endothelial Growth Factor Polymorphism +405 G/C Is Associated With Early Stage of Diabetic Nephropathy in Patients With Type 2 Diabetes

Endocrine Abstracts
2014English

Anti-Vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy

2010English

Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome

Archives of Rheumatology
Rheumatology
2019English

Plasma From Preeclamptic Women Increases Blood-Brain Barrier Permeability: Role of Vascular Endothelial Growth Factor Signaling

Hypertension
Internal Medicine
2010English

Upregulated Expression of Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1996English

Vascular Endothelial Growth Factor

English

Vascular Endothelial Growth Factor

English

Homocysteine and Insulin Levels in Type 2 Diabetic Patients

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2000English

Association of Plasma Fetuin-A Levels and Peripheral Vascular Disease in Type 2 Diabetic Patients

Endocrine Abstracts
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy